Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1992 Aug;51(8):1014–1018. doi: 10.1136/ard.51.8.1014

Role of substance P in inflammatory arthritis.

N E Garrett 1, P I Mapp 1, S C Cruwys 1, B L Kidd 1, D R Blake 1
PMCID: PMC1004819  PMID: 1384440

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews P. V., Helme R. D., Thomas K. L. NK-1 receptor mediation of neurogenic plasma extravasation in rat skin. Br J Pharmacol. 1989 Aug;97(4):1232–1238. doi: 10.1111/j.1476-5381.1989.tb12583.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beresford I. J., Birch P. J., Hagan R. M., Ireland S. J. Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345. Br J Pharmacol. 1991 Oct;104(2):292–293. doi: 10.1111/j.1476-5381.1991.tb12423.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brain S. D., Williams T. J., Tippins J. R., Morris H. R., MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature. 1985 Jan 3;313(5997):54–56. doi: 10.1038/313054a0. [DOI] [PubMed] [Google Scholar]
  4. Devillier P., Weill B., Renoux M., Menkès C., Pradelles P. Elevated levels of tachykinin-like immunoreactivity in joint fluids from patients with rheumatic inflammatory diseases. N Engl J Med. 1986 May 15;314(20):1323–1323. doi: 10.1056/NEJM198605153142018. [DOI] [PubMed] [Google Scholar]
  5. Docherty A. J., Murphy G. The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins. Ann Rheum Dis. 1990 Jun;49 (Suppl 1):469–479. [PubMed] [Google Scholar]
  6. Engberg G., Svensson T. H., Rosell S., Folkders K. A synthetic peptide as an antagonist of substance P. Nature. 1981 Sep 17;293(5829):222–223. doi: 10.1038/293222a0. [DOI] [PubMed] [Google Scholar]
  7. Fink T., Weihe E. Multiple neuropeptides in nerves supplying mammalian lymph nodes: messenger candidates for sensory and autonomic neuroimmunomodulation? Neurosci Lett. 1988 Jul 19;90(1-2):39–44. doi: 10.1016/0304-3940(88)90783-5. [DOI] [PubMed] [Google Scholar]
  8. Foreman J. C., Jordan C. C., Oehme P., Renner H. Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin. J Physiol. 1983 Feb;335:449–465. doi: 10.1113/jphysiol.1983.sp014543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Foreman J., Jordan C. Histamine release and vascular changes induced by neuropeptides. Agents Actions. 1983 Apr;13(2-3):105–116. doi: 10.1007/BF01967311. [DOI] [PubMed] [Google Scholar]
  10. Gitter B. D., Waters D. C., Bruns R. F., Mason N. R., Nixon J. A., Howbert J. J. Species differences in affinities of non-peptide antagonists for substance P receptors. Eur J Pharmacol. 1991 May 17;197(2-3):237–238. doi: 10.1016/0014-2999(91)90532-u. [DOI] [PubMed] [Google Scholar]
  11. Grönblad M., Konttinen Y. T., Korkala O., Liesi P., Hukkanen M., Polak J. M. Neuropeptides in synovium of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol. 1988 Dec;15(12):1807–1810. [PubMed] [Google Scholar]
  12. Harmar A., Schofield J. G., Keen P. Substance P biosynthesis in dorsal root ganglia: an immunochemical study of [35S]methionine and [3H]proline incorporation in vitro. Neuroscience. 1981;6(10):1917–1922. doi: 10.1016/0306-4522(81)90031-2. [DOI] [PubMed] [Google Scholar]
  13. Hartung H. P., Toyka K. V. Activation of macrophages by substance P: induction of oxidative burst and thromboxane release. Eur J Pharmacol. 1983 May 6;89(3-4):301–305. doi: 10.1016/0014-2999(83)90511-3. [DOI] [PubMed] [Google Scholar]
  14. Hartung H. P., Wolters K., Toyka K. V. Substance P: binding properties and studies on cellular responses in guinea pig macrophages. J Immunol. 1986 May 15;136(10):3856–3863. [PubMed] [Google Scholar]
  15. Helke C. J., Krause J. E., Mantyh P. W., Couture R., Bannon M. J. Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms. FASEB J. 1990 Apr 1;4(6):1606–1615. [PubMed] [Google Scholar]
  16. Hökfelt T., Kellerth J. O., Nilsson G., Pernow B. Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurons. Brain Res. 1975 Dec 19;100(2):235–252. doi: 10.1016/0006-8993(75)90481-3. [DOI] [PubMed] [Google Scholar]
  17. Hökfelt T., Kellerth J. O., Nilsson G., Pernow B. Substance p: localization in the central nervous system and in some primary sensory neurons. Science. 1975 Nov 28;190(4217):889–890. doi: 10.1126/science.242075. [DOI] [PubMed] [Google Scholar]
  18. Katayama M., Nadel J. A., Bunnett N. W., Di Maria G. U., Haxhiu M., Borson D. B. Catabolism of calcitonin gene-related peptide and substance P by neutral endopeptidase. Peptides. 1991 May-Jun;12(3):563–567. doi: 10.1016/0196-9781(91)90102-u. [DOI] [PubMed] [Google Scholar]
  19. Keen P., Harmar A. J., Spears F., Winter E. Biosynthesis, axonal transport and turnover of neuronal substance P. Ciba Found Symp. 1982;(91):145–164. doi: 10.1002/9780470720738.ch9. [DOI] [PubMed] [Google Scholar]
  20. Kidd B. L., Mapp P. I., Gibson S. J., Polak J. M., O'Higgins F., Buckland-Wright J. C., Blake D. R. A neurogenic mechanism for symmetrical arthritis. Lancet. 1989 Nov 11;2(8672):1128–1130. doi: 10.1016/s0140-6736(89)91491-8. [DOI] [PubMed] [Google Scholar]
  21. Krause J. E., Chirgwin J. M., Carter M. S., Xu Z. S., Hershey A. D. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc Natl Acad Sci U S A. 1987 Feb;84(3):881–885. doi: 10.1073/pnas.84.3.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lam F. Y., Ferrell W. R. Capsaicin suppresses substance P-induced joint inflammation in the rat. Neurosci Lett. 1989 Oct 23;105(1-2):155–158. doi: 10.1016/0304-3940(89)90028-1. [DOI] [PubMed] [Google Scholar]
  23. Lam F. Y., Ferrell W. R. Inhibition of carrageenan induced inflammation in the rat knee joint by substance P antagonist. Ann Rheum Dis. 1989 Nov;48(11):928–932. doi: 10.1136/ard.48.11.928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Larsson J., Ekblom A., Henriksson K., Lundeberg T., Theodorsson E. Concentration of substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis. Scand J Rheumatol. 1991;20(5):326–335. doi: 10.3109/03009749109096808. [DOI] [PubMed] [Google Scholar]
  25. Larsson J., Ekblom A., Henriksson K., Lundeberg T., Theodorsson E. Immunoreactive tachykinins, calcitonin gene-related peptide and neuropeptide Y in human synovial fluid from inflamed knee joints. Neurosci Lett. 1989 May 22;100(1-3):326–330. doi: 10.1016/0304-3940(89)90707-6. [DOI] [PubMed] [Google Scholar]
  26. Levine J. D., Clark R., Devor M., Helms C., Moskowitz M. A., Basbaum A. I. Intraneuronal substance P contributes to the severity of experimental arthritis. Science. 1984 Nov 2;226(4674):547–549. doi: 10.1126/science.6208609. [DOI] [PubMed] [Google Scholar]
  27. Levine J. D., Collier D. H., Basbaum A. I., Moskowitz M. A., Helms C. A. Hypothesis: the nervous system may contribute to the pathophysiology of rheumatoid arthritis. J Rheumatol. 1985 Jun;12(3):406–411. [PubMed] [Google Scholar]
  28. Lotz M., Carson D. A., Vaughan J. H. Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science. 1987 Feb 20;235(4791):893–895. doi: 10.1126/science.2433770. [DOI] [PubMed] [Google Scholar]
  29. Lundberg J. M., Terenius L., Hökfelt T., Martling C. R., Tatemoto K., Mutt V., Polak J., Bloom S., Goldstein M. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand. 1982 Dec;116(4):477–480. doi: 10.1111/j.1748-1716.1982.tb07171.x. [DOI] [PubMed] [Google Scholar]
  30. Mantyh C. R., Gates T. S., Zimmerman R. P., Welton M. L., Passaro E. P., Jr, Vigna S. R., Maggio J. E., Kruger L., Mantyh P. W. Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease. Proc Natl Acad Sci U S A. 1988 May;85(9):3235–3239. doi: 10.1073/pnas.85.9.3235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Mapp P. I., Kidd B. L., Gibson S. J., Terry J. M., Revell P. A., Ibrahim N. B., Blake D. R., Polak J. M. Substance P-, calcitonin gene-related peptide- and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience. 1990;37(1):143–153. doi: 10.1016/0306-4522(90)90199-e. [DOI] [PubMed] [Google Scholar]
  32. Marshall K. W., Chiu B., Inman R. D. Substance P and arthritis: analysis of plasma and synovial fluid levels. Arthritis Rheum. 1990 Jan;33(1):87–90. doi: 10.1002/art.1780330111. [DOI] [PubMed] [Google Scholar]
  33. Nilsson J., von Euler A. M., Dalsgaard C. J. Stimulation of connective tissue cell growth by substance P and substance K. Nature. 1985 May 2;315(6014):61–63. doi: 10.1038/315061a0. [DOI] [PubMed] [Google Scholar]
  34. Pereira da Silva J. A., Carmo-Fonseca M. Peptide containing nerves in human synovium: immunohistochemical evidence for decreased innervation in rheumatoid arthritis. J Rheumatol. 1990 Dec;17(12):1592–1599. [PubMed] [Google Scholar]
  35. Pernow B. Substance P. Pharmacol Rev. 1983 Jun;35(2):85–141. [PubMed] [Google Scholar]
  36. Ruff M. R., Wahl S. M., Pert C. B. Substance P receptor-mediated chemotaxis of human monocytes. Peptides. 1985;6 (Suppl 2):107–111. doi: 10.1016/0196-9781(85)90142-1. [DOI] [PubMed] [Google Scholar]
  37. Snider R. M., Constantine J. W., Lowe J. A., 3rd, Longo K. P., Lebel W. S., Woody H. A., Drozda S. E., Desai M. C., Vinick F. J., Spencer R. W. A potent nonpeptide antagonist of the substance P (NK1) receptor. Science. 1991 Jan 25;251(4992):435–437. doi: 10.1126/science.1703323. [DOI] [PubMed] [Google Scholar]
  38. Stanisz A. M., Befus D., Bienenstock J. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J Immunol. 1986 Jan;136(1):152–156. [PubMed] [Google Scholar]
  39. Tissot M., Pradelles P., Giroud J. P. Substance-P-like levels in inflammatory exudates. Inflammation. 1988 Feb;12(1):25–35. doi: 10.1007/BF00915889. [DOI] [PubMed] [Google Scholar]
  40. White D. M., Helme R. D. Release of substance P from peripheral nerve terminals following electrical stimulation of the sciatic nerve. Brain Res. 1985 Jun 10;336(1):27–31. doi: 10.1016/0006-8993(85)90412-3. [DOI] [PubMed] [Google Scholar]
  41. Wilkinson K. D., Lee K. M., Deshpande S., Duerksen-Hughes P., Boss J. M., Pohl J. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science. 1989 Nov 3;246(4930):670–673. doi: 10.1126/science.2530630. [DOI] [PubMed] [Google Scholar]
  42. Winyard P. G., Zhang Z., Chidwick K., Blake D. R., Carrell R. W., Murphy G. Proteolytic inactivation of human alpha 1 antitrypsin by human stromelysin. FEBS Lett. 1991 Feb 11;279(1):91–94. doi: 10.1016/0014-5793(91)80258-5. [DOI] [PubMed] [Google Scholar]
  43. Zhang Z., Winyard P. G., Chidwick K., Farrell A., Pemberton P., Carrell R. W., Blake D. R. Increased proteolytic cleavage of alpha 1-antitrypsin (alpha 1-proteinase inhibitor) in knee-joint synovial fluid from patients with rheumatoid arthritis. Biochem Soc Trans. 1990 Oct;18(5):898–899. doi: 10.1042/bst0180898. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES